NKp30 Polyclonal Antibody

货号：ES5448
价格：面议
点击：2122

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human;Rat
别称	NCR3; 1C7; LY117; Natural cytotoxicity triggering receptor 3; Activating natural killer receptor p30; Natural killer cell p30-related protein; NK-p30; NKp30; CD antigen CD337

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Camrelizumab Neutralizing Recombinant Antibody \|抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体)	469
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	252
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	444
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	202
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	312
Anti-Infliximab Non-Neutralizing Recombinant Antibody \|抗英夫利昔单抗非中和重组抗体(靶标：英夫利昔单抗非中和抗体)	445
Anti-Infliximab Non-Neutralizing Recombinant Antibody \|抗英夫利昔单抗非中和重组抗体(靶标：英夫利昔单抗非中和抗体)	394
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	488
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	343
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	139
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	309
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	226
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	470
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	380
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	353
Anti-Elotuzumab Non-Neutralizing Recombinant Antibody\|抗埃罗妥珠单抗非中和重组抗体(靶标：埃罗妥珠单抗非中和抗体)	488
Anti-Elotuzumab Neutralizing Recombinant Antibody \|抗埃罗妥珠单抗中和重组抗体(靶标：埃罗妥珠单抗中和抗体)	146
Anti-Elotuzumab Neutralizing Recombinant Antibody \|抗埃罗妥珠单抗中和重组抗体(靶标：埃罗妥珠单抗中和抗体)	230
Anti-Oleclumab Neutralizing Recombinant Antibody \|抗奥乐克单抗中和重组抗体(靶标：奥乐克单抗中和抗体)	207
Anti-Oleclumab Neutralizing Recombinant Antibody \|抗奥乐克单抗中和重组抗体(靶标：奥乐克单抗中和抗体)	214

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00